&bgr;3-adrenergic receptor agonists
US6355805B1 · kind B1 · utility
7Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1999 |
| Grant date | Mar 12, 2002 |
| Priority date | — |
| Expiry date | Jun 8, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to multibinding compounds which are &bgr;3 adrenergic receptor agonists and are therefore useful in the treatment and prevention of metabolic disorders such as obesity, diabetes, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.